-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Monte Rosa Therapeutics, Lowers Price Target to $10

Benzinga·03/21/2025 19:10:19
Listen to the news
Wells Fargo analyst Derek Archila maintains Monte Rosa Therapeutics (NASDAQ:GLUE) with a Equal-Weight and lowers the price target from $11 to $10.